Table 2.

Markers of maternal disease status during pregnancy in HIV-infected women by type of antepartum antiretroviral therapy.

	ART with a protease inhibitor	ART without a protease inhibitor	No ART	p value
	n = 597	n = 230	n = 177
Duration of diagnosis, years	2.0 [0.5, 4.7]	1.0 [0.4, 2.7]	0.2 [0, 1.0]	<0.001
Viral load, copies/mL
At presentation	2,054 [37, 20,965]	1,372 [0, 12,266]	4,770 [643, 20,400]	0.02
At delivery	0 [0, 251]	0 [0, 1347]	2,540 [0, 25,940]	<0.001
CD4 count, cells/mm3
At presentation	463 [299, 626]	456 [314, 624]	557 [375, 747]	0.001
At delivery	524 [372, 693]	505 [349, 677]	565 [337, 717]	0.349

Data reported as median [quartiles].